INVO Fertility (IVF) Amortizatization of Intangibles (2012 - 2025)
INVO Fertility (IVF) posted quarterly Amortizatization of Intangibles of $1736.0 for Q3 2025, down 99.07% year-over-year from $186649.0 in Q3 2024, and down 96.04% quarter-over-quarter from $43853.0 in Q2 2025.
INVO Fertility (IVF) Amortizatization of Intangibles (2012 - 2025) Analysis & Trends
INVO Fertility (IVF) has reported Amortizatization of Intangibles for 11 consecutive years, with $1736.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Amortizatization of Intangibles fell 99.07% year-over-year to $1736.0; the TTM figure through Sep 2025 stood at $219268.0 (down 65.93% YoY), while the FY2024 annual figure was $622283.0, down 13.59% from the prior year.
- Amortizatization of Intangibles fell to $1736.0 in Q3 2025 per IVF's latest filing, from $43853.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $860155.0 in Q1 2021 and bottomed at $1736.0 in Q3 2025.
- Historically, Amortizatization of Intangibles has averaged $160539.6 across 5 years, with a median of $102953.5 in 2023.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles jumped 15457.15% — and 2025, when it slumped 99.07%.
- INVO Fertility's Amortizatization of Intangibles stood at $173351.0 in 2021, then tumbled by 69.63% to $52644.0 in 2022, then jumped by 104.9% to $107869.0 in 2023, then retreated by 19.7% to $86624.0 in 2024, then tumbled by 98.0% to $1736.0 in 2025.
- Business Quant data shows IVF's Amortizatization of Intangibles at $1736.0 in Q3 2025, $43853.0 in Q2 2025, and $87055.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | - |
| 10 | INVO Fertility | 2.42 Mn | 2.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 654,102.00 |
| Dec 31, 2025 | 654,102.00 |
| Sep 30, 2025 | 1,736.00 |
| Sep 30, 2025 | 1,736.00 |
| Jun 30, 2025 | 43,853.00 |
| Jun 30, 2025 | 43,853.00 |
| Mar 31, 2025 | 87,055.00 |
| Mar 31, 2025 | 87,055.00 |
| Dec 31, 2024 | 86,624.00 |
| Dec 31, 2024 | 86,624.00 |
| Sep 30, 2024 | 186,649.00 |
| Sep 30, 2024 | 186,649.00 |
| Jun 30, 2024 | 250,972.00 |
| Jun 30, 2024 | 250,972.00 |
| Mar 31, 2024 | 98,038.00 |
| Mar 31, 2024 | 98,038.00 |
| Dec 31, 2023 | 107,869.00 |
| Dec 31, 2023 | 107,869.00 |
| Sep 30, 2023 | 311,161.00 |
| Sep 30, 2023 | 311,161.00 |